Qube Research & Technologies (QRT)
RNAC icon

Qube Research & Technologies (QRT)’s Cartesian Therapeutics RNAC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,868
Closed -$620K – 2914
2023
Q1 		$620K Buy
14,868
+12,633
+565% +$594K ﹤0.01% 1481
2022
Q4 		$75.8K Buy
2,235
+235
+12% +$10K ﹤0.01% 2065
2022
Q3 		$98K Sell
2,000
-1,648
-45% -$90.5K ﹤0.01% 1976
2022
Q2 		$143K Buy
+3,648
New +$108K ﹤0.01% 1817
2022
Q1 		– Sell
-2,205
Closed -$216K – 2919
2021
Q4 		$216K Buy
+2,205
New +$237K ﹤0.01% 1940
2021
Q2 		– Sell
-1,114
Closed -$151K – 2725
2021
Q1 		$151K Buy
+1,114
New +$138K ﹤0.01% 1700

Other funds holding RNAC

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RNAC Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Cartesian Therapeutics (RNAC) in Q2 2023, closing a stake of 14,868 shares — an estimated $620K sold.

Qube Research & Technologies (QRT) first reported a position in RNAC in Q1 2021 and held it in 6 quarters. The position peaked at $620K in Q1 2023. 92 funds tracked by Wall St. Rank hold RNAC as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining Cartesian Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 14,868 Cartesian Therapeutics shares in Q2 2023, an estimated $620K.
  • Qube Research & Technologies (QRT) first reported a position in Cartesian Therapeutics in Q1 2021 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Cartesian Therapeutics position peaked at $620K in Q1 2023.
  • 92 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.